The report maintains a BUY rating with a Sep-27 target price of INR 700, valuing the stock at 45x P/E, and expects faster H2 revenue growth of ~18% along with margin expansion in Q3, while flagging that a stronger Q3 performance is critical to rebuilding investor confidence after a ~28% YTD stock decline.
Read this note →Bikaji Foods International Limited
NSE BIKAJI BSE 543653 INE00E101023
0 filings · 0 analysed
479.95
+0.22%
over today
Prices from Yahoo Finance, NSE close, delayed — indicative only, not for dealing.
Targets, and what happened next
What each house published, and where the price has gone since. Orivam issues no calls of its own and takes no view on these.
| House | Published | Call | Entry | Target | Now | Progress | Standing |
|---|---|---|---|---|---|---|---|
| HDFC Securities (HSIE Research) | 08 Oct 2026, 08:26 | long | 468.65 | 700.00 | 476.35 | 3% | open by 2027-10-08 |
| HDFC Securities | 05 Oct 2026, 16:07 | long | 487.00 | 700.00 | 476.35 | -5% | open by 2027-10-05 |
Deadlines: 0 stated by the house, the rest set by Orivam’s convention — ten trading days for a technical call, twelve months for a price target. A target with no date cannot be judged, so one has to be chosen.
What the desks said
The note says HSIE maintains BUY with a Sep-27 target of INR 700 at 45x P/E (a ~20% discount to the three-year forward average), noting management guidance of 100-150bps FY27 margin compression (200-250bps in Q2FY27E), weighted average inflation of ~7% partly offset by a 5% price hike, an 8% cut to FY27E EPS, and that the stock is down ~35% YTD with a strong Q3 seen as pivotal for sentiment.
Read this note →The report expects Bikaji's revenue to grow 11% YoY but EBITDA and adjusted PAT to decline 16% and 15% respectively in Q2FY27E.
Read this note →Announcement timeline
No filings stored for this company yet.
Never miss the next one.
Orivam emails what the research desks published each trading morning, attributed and linked to the original notes. Free.
Get the daily brief